Finally, given the mounting evidence suggesting a mechanistic association of abnormal Wnt signaling with Alzheimer's and Parkinson's diseases [61], our findings suggest that SCD5 may be a molecular link between signaling and lipogenic pathways mechanisms and these neurodegenerative conditions. This evidence concerns the gene SCD5 and Parkinson disease.